title: Direct conversion of porcine embryonic fibroblasts into adipocytes by chemical molecules.
abstract: Direct reprogramming of terminally differentiated cells to specify different cell types may allow somatic cells to be reprogrammed to an alternative, differentiated fate without intervening stem or progenitor cells. Recent studies have shown that the conversion of fibroblasts to other cell lines can be accomplished by the introduction of master regulator transcription factors. These findings have raised the question as to whether chemical molecules could replace transcription factor cocktails to directly alter defined somatic cell fate. Here, we demonstrate the generation of adipocytes directly from porcine embryonic fibroblasts (PEFs) using defined chemical molecules. Treatment with SB431542 and Thiazovivin, which are transforming growth factor-beta (TGF-β) and ROCK signaling pathway inhibitors, respectively, allowed PEFs to directly convert to fat-laden adipocytes. These induced adipocytes expressed multiple fat marker genes. We believe that these findings demonstrate that committed adipocytes can be directly reprogrammed from differentiated somatic cells using defined chemical molecules. The generation of adipocytes from nonadipogenic lineages has important implications for studies of adipogenesis, obesity modeling, and regenerative medicine. Additionally, these findings may enlighten a new method that direct reprogramming committed cell lines to other somatic cells using defined chemical molecules.
authors.affiliation: Jilin Provincial Key Laboratory of Animal Embryo Engineering, College of Animal Science and Veterinary Medicine, Jilin University, Changchun, Jilin 130062, People's Republic of China.
authors.forename: Jianguo
authors.initials: J
authors.lastname: Zhu
authors.forename: Daxin
authors.initials: D
authors.lastname: Pang
authors.forename: Yang
authors.initials: Y
authors.lastname: Zhou
authors.forename: Xiaochun
authors.initials: X
authors.lastname: Tang
authors.forename: Yongye
authors.initials: Y
authors.lastname: Huang
authors.forename: Wanhua
authors.initials: W
authors.lastname: Xie
authors.forename: Fei
authors.initials: F
authors.lastname: Gao
authors.forename: Liangxue
authors.initials: L
authors.lastname: Lai
authors.forename: Mingjun
authors.initials: M
authors.lastname: Zhang
authors.forename: Hongsheng
authors.initials: H
authors.lastname: Ouyang
mesh_terms: D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D050156:Adipogenesis / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects* / Q000235:genetics; D002460:Cell Line; D065150:Cellular Reprogramming / Q000187:drug effects; D004149:Dioxoles / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D053595:Embryonic Stem Cells / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D005333:Fetus / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology*; D044968:Regenerative Medicine; D013552:Swine; D013844:Thiazoles / Q000494:pharmacology*
chemical_list: C459179:4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide; D001549:Benzamides; D004149:Dioxoles; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; C545214:thiazovivin